[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 479
Citations 0
Invited Commentary
June 2015

Screening Strategies for Pancreatic Cancer in High-Risk PatientsOpportunities to Make a Real Impact But Many Questions and Challenges Still Ahead

Author Affiliations
  • 1Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois
JAMA Surg. 2015;150(6):518-519. doi:10.1001/jamasurg.2015.0391

In this issue of JAMA Surgery, Del Chiaro and colleagues1 report the early results of a magnetic resonance imaging (MRI)–based Swedish screening program for asymptomatic patients with an increased risk for familial pancreatic cancer. The goals of this study were to determine whether a high-risk population of patients could be screened in a cost-efficient fashion with a noninvasive screening test and whether this strategy yielded enough premalignant lesions and early cancers to justify the strategy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×